On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies Inc.’s MGRM Monogram mBôs TKA System. Ben Sexson, Monogram’s Chief Executive Officer, commented, “We are particularly excited about the system’s performance and its potential to […]
Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s MRK Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH). Sotatercept is used, in combination with other medicines, to treat PAH in adults with moderate
SiriusPoint Ltd SPNT stock is trading higher on Tuesday after the specialty insurer and reinsurer announced the repurchase of all SiriusPoint common shares and warrants held by CM Bermuda Limited for $733 million. Following the closing of the repurchase transaction,
Why Is Insurer SiriusPoint Stock Trading Higher On Tuesday? – SiriusPoint (NYSE:SPNT) Read More »
According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, with mixed sentiment shaping investor outlook for 2025. Despite strong fundamentals and advancements in drug pipelines, factors such as political uncertainty and sector
On Thursday, Merck & Co Inc MRK revealed topline results from two pivotal Phase 3 trials of a two-drug regimen of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection. The trials included patients who were virologically suppressed on different antiretroviral therapy regimens,
On Tuesday, Arvinas Inc. ARVN and Pfizer Inc. PFE announced preliminary data from the ongoing Phase 1b portion of the TACTIVE-U sub-study of vepdegestrant in combination with abemaciclib for locally advanced or metastatic estrogen receptor-positive/human epidermal growth factor receptor 2
On Wednesday, Eli Lilly And Co LLY revealed topline data from the SURMOUNT-5 phase 3b trial evaluating the efficacy and safety of Zepbound (tirzepatide) compared with Novo Nordisk A/S’ NVO Wegovy (semaglutide) in adults with obesity, or overweight with at least one of the
On Wednesday, Donald Trump, the Republican candidate and former president, was elected to the highest office again, marking a return to an administration. His second term is likely to impact U.S. healthcare. Trump has been unclear about his healthcare policy
On Thursday, Cigna Corporation CI reported third-quarter sales of $63.7 billion, up 30% year-over-year, beating the consensus of $59.35 billion. The increase was primarily driven by significant growth in Evernorth Health Services, reflecting large client wins and strong specialty volume growth. Adjusted income
On Sunday, Corxel Pharmaceuticals and LENZ Therapeutics LENZ released topline data from the Phase 3 JX07001 trial of LNZ100 in patients with presbyopia in China. Presbyopia is a normal part of aging, making it difficult to see objects up close. In this
